# Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine Headaches

> **NCT04341298** · NA · COMPLETED · sponsor: **Avulux, Inc.** · enrollment: 78 (actual)

## Conditions studied

- Migraine

## Interventions

- **OTHER:** 11-point pain scale
- **OTHER:** Headache diary
- **DEVICE:** Avulux®
- **DEVICE:** Sham Avulux®

## Key facts

- **NCT ID:** NCT04341298
- **Lead sponsor:** Avulux, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-06
- **Primary completion:** 2020-08-26
- **Final completion:** 2020-08-26
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2023-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04341298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04341298, "Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine Headaches". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04341298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*